- Our World
- Our Business
- Life at Lupin
- Global Sites
Lupin’s ROW markets including South Africa and Japan, clocked in revenues of 24,522 million during FY 2015, a growth of 6% and contributed 19% to the Company’s global consolidated revenues.
These markets are the fastest growing growth opportunity in the global pharmaceutical market and are expected to grow to USD 400 billion by FY 2020. Our growing presence and leadership credentials in markets like Japan, South Africa and Mexico coupled with our efforts to enter new markets with meaningful acquisitions are going to help us address these growth opportunities.